Han 2016.
| Methods | RCT
Method of randomisation: not stated
Blinding of outcome assessors: stated as 'yes'
Adverse events: none
Deaths: none
Dropouts: 4 in control group (2 refused and 2 dropped) ITT: no |
|
| Participants | Country: Republic of Korea 60 participants (30 in treatment group, 30 in control group) Non‐ambulatory at start of study Mean age: 68 years in experimental group and 63 years in control group Inclusion criteria: clinical diagnosis of stroke < 3 months after stroke onset, first‐ever stroke, dependent ambulation with severe gait impairment (FAC < 2), and sufficient cognition to understand procedures and provide informed consent Exclusion criteria: contraindications for RAGT therapy; cerebellar or brainstem lesions that could affect autonomic or balance function; musculoskeletal disease involving the lower limbs, such as severe painful arthritis, osteoporosis, amputation, or joint contracture; and other concurrent neurological diseases (e.g. Parkinson's disease, multiple sclerosis, etc.) |
|
| Interventions | 2 arms:
|
|
| Outcomes | Outcomes were recorded at baseline and after the 4‐week intervention; all outcome parameters were measured within 3 days before and after 20 sessions of training:
|
|
| Notes | ||
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Unclear risk | Method of randomisation not described. |
| Allocation concealment (selection bias) | Unclear risk | Allocation concealment not described. |
| Blinding of outcome assessment (detection bias) All outcomes | Low risk | A physiatrist (rehabilitation doctor) who remained blinded to participant group and treatment throughout the entire study analysed outcome measures. |
| Incomplete outcome data (attrition bias) All outcomes | High risk | No ITT |